Ganglioside Induces Caveolin-1 Redistribution and Interaction with the Epidermal Growth Factor Receptor
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Although caveolin-1 is thought to facilitate the interaction of receptors and signaling components, its role in epidermal growth factor receptor (EGFR) signaling remains poorly understood. Ganglioside GM3 inhibits EGFR autophosphorylation and may thus affect the interaction of caveolin-1 and the EGFR. We report here that endogenous overexpression of GM3 leads to the clustering of GM3 on the cell membrane of the keratinocyte-derived SCC12 cell line and promotes co-immunoprecipitation of caveolin-1 and GM3 with the EGFR. Overexpression of GM3 does not affect EGFR distribution but shifts caveolin-1 to the detergent-soluble, EGFR-containing region; consistently, caveolin-1 is retained in the detergent-insoluble membrane when ganglioside is depleted. GM3 overexpression inhibits EGFR tyrosine phosphorylation and receptor dimerization and concurrently increases both the content and tyrosine phosphorylation of EGFR-associated caveolin-1, providing evidence that tyrosine phosphorylation of caveolin-1 inhibits EGFR signaling. Consistently, depletion of ganglioside both increases EGFR phosphorylation and prevents the EGF-induced tyrosine phosphorylation of caveolin-1. GM3 also induces delayed serine phosphorylation of EGFR-unassociated caveolin-1, suggesting a role for serine phosphorylation of caveolin-1 in regulating EGFR signaling. These studies suggest that GM3 modulates the caveolin-1/EGFR association and is critical for the EGF-induced tyrosine phosphorylation of caveolin-1 that is associated with its inhibition of EGFR activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bremer, E. G., Schlessinger, J., & Hakomori, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35954-9 · Cited by 706
Pike, L. J., & Miller, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22298 · Cited by 374
Distinction between signaling mechanisms in lipid rafts vs. caveolae
Sowa, G., Pypaert, M., & Sessa, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241409998 · Cited by 233
Zhou, Q., Hakomori, S., Kitamura, K., & Igarashi, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42121-1 · Cited by 131
Cited by
Lipid rafts: heterogeneity on the high seas
PIKE, L. J. (2004) · Biochemical Journal · doi:10.1042/bj20031672 · Cited by 703
Mammalian sialidases: Physiological and pathological roles in cellular functions
Miyagi, T., & Yamaguchi, K. (2012) · Glycobiology · doi:10.1093/glycob/cws057 · Cited by 382
Regulation of human EGF receptor by lipids
Coskun, Ü., Grzybek, M., Drechsel, D., & Simons, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105666108 · Cited by 316
“Other proteins such as caveolin, a cholesterol-binding protein were reported to modulate these interactions (17).”
BackgroundCaveolin-1 in tumor progression: the good, the bad and the ugly
Goetz, J. G., Lajoie, P., Wiseman, S. M., & Nabi, I. R. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9160-9 · Cited by 299
Glycosphingolipids: synthesis and functions
D'Angelo, G., Capasso, S., Sticco, L., & Russo, D. (2013) · FEBS Journal · doi:10.1111/febs.12559 · Cited by 298
Metadata
- Authors
- Wang, X.-Q., Sun, P., & Paller, A. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 49
- Pages
- 47028-47034
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980827605
- Cited by
- 83
- References
- 4
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.